Table 5 Impact of the patient decision aid (n = 281)
From: Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
|
Comparison group* n = 158 |
Intervention group* n = 123 | P a | |
|---|---|---|---|
| Perceived role in decision-making (CPS), % (n) | |||
| (Mostly) doctor | 25 % (39) | 14 % (17) | |
| Shared | 70 % (111) | 73 % (90) | |
| (Mostly) patient | 5 % (8) | 13 % (16) | 0.01b |
| Satisfaction with decision and decision-making process | |||
| Satisfaction with participation (range 1–5) | 4.6 ± 0.6 (144) | 4.6 ± 0.6 (115) | n.s. |
| Satisfaction with received information (range 0–21) | 15.7 ± 4.9 (130) | 15.3 ± 5.7 (106) | n.s. |
| Informed choice (DES) (range 1–5) | 4.2 ± 1.0 (145) | 4.3 ± 0.9 (115) | n.s. |
| Decision-control (DES) (range 1–5) | 4.6 ± 0.5 (146) | 4.6 ± 0.7 (114) | n.s. |
| Satisfaction-uncertainty (DES) (range 1–5)c | 4.0 ± 0.8 (147) | 4.1 ± 0.7 (116) | n.s. |
| Consistency with personal values (SWD) | 4.2 ± 1.0 (148) | 4.5 ± 0.8 (112) | 0.02 |
| Other categories | |||
| Beliefs about medication - necessity (range 5–25) | 18.6 ± 4.5 (137) | 19.6 ± 4.6 (87) | n.s. |
| Beliefs about medication - concerns (range 5 − 25) | 13.8 ± 4.1 (136) | 12.9 ± 4.9 (90) | n.s. |
| Medication adherence (MMAS) (range 0 − 8)d | 7.2 ± 1.4 (129) | 7.2 ± 1.4 (102) | n.s. |
| Trust in physician (CPQ) (range 1 − 5) | 4.8 ± 0.5 (155) | 4.8 ± 0.4 (120) | n.s. |
| Number of treatment options suggested by rheumatologist, % (n) | |||
| 1 option | 88 % (137) | 54 % (60) | |
| > 1 option | 12 % (18) | 46 % (51) | 0.000 |